GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (LTS:0IV3) » Definitions » Dividend-Payout-to-FFO

Geron (LTS:0IV3) Dividend-Payout-to-FFO


View and export this data going back to 2018. Start your Free Trial

What is Geron Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Geron Business Description

Traded in Other Exchanges
Address
919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.